Extended Data Fig. 3: Subgroup analyses of screening effectiveness.

a, Stage-specific survival for screen-detected cancers with known stage at diagnosis (n = 323 patients). b, Association between screening and effectiveness of overall survival. Data are displayed as the hazard ratio ±95% CI (screening group n = 327 patients, control group n = 1,446 patients).